NO20034647L - Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-ligander - Google Patents
Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-liganderInfo
- Publication number
- NO20034647L NO20034647L NO20034647A NO20034647A NO20034647L NO 20034647 L NO20034647 L NO 20034647L NO 20034647 A NO20034647 A NO 20034647A NO 20034647 A NO20034647 A NO 20034647A NO 20034647 L NO20034647 L NO 20034647L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxyclylalkoxy
- alkylaminobenzazole
- hydroxytryptamine
- alkyloxy
- ligands
- Prior art date
Links
- 125000003545 alkoxy group Chemical group 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28564401P | 2001-04-20 | 2001-04-20 | |
| PCT/US2002/012512 WO2002085853A2 (en) | 2001-04-20 | 2002-04-19 | Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034647D0 NO20034647D0 (no) | 2003-10-17 |
| NO20034647L true NO20034647L (no) | 2003-11-20 |
Family
ID=23095117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034647A NO20034647L (no) | 2001-04-20 | 2003-10-17 | Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-ligander |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6831094B2 (no) |
| EP (1) | EP1392682A2 (no) |
| JP (1) | JP2004526781A (no) |
| KR (1) | KR20030088507A (no) |
| CN (1) | CN1293073C (no) |
| AR (1) | AR034588A1 (no) |
| AU (1) | AU2002309585B2 (no) |
| BR (1) | BR0209047A (no) |
| CA (1) | CA2444036A1 (no) |
| EA (1) | EA200301143A1 (no) |
| HU (1) | HUP0303801A2 (no) |
| IL (1) | IL158448A0 (no) |
| MX (1) | MXPA03009490A (no) |
| NO (1) | NO20034647L (no) |
| PL (1) | PL366639A1 (no) |
| WO (1) | WO2002085853A2 (no) |
| ZA (1) | ZA200309009B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0311593A (pt) * | 2002-06-05 | 2005-04-26 | Hoffmann La Roche | Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc |
| BR0316962A (pt) * | 2002-12-03 | 2005-10-25 | Hoffmann La Roche | Aminoalcoxiindóis como ligantes para o receptor de 5-ht6 para o tratamento de distúrbios do snc |
| TW200505904A (en) * | 2003-02-14 | 2005-02-16 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
| WO2007021711A2 (en) * | 2005-08-15 | 2007-02-22 | Wyeth | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| JP2009504738A (ja) * | 2005-08-15 | 2009-02-05 | ワイス | ５−ヒドロキシトリプタミン−６リガンドとしてのアジニル−３−スルホニルインダゾール誘導体 |
| CA2648055A1 (en) * | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2007120596A1 (en) * | 2006-04-12 | 2007-10-25 | Wyeth | DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS |
| AU2007255042A1 (en) * | 2006-06-01 | 2007-12-13 | Wyeth | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| US20090023925A1 (en) * | 2007-06-28 | 2009-01-22 | Wyeth | N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| CN102958927A (zh) | 2010-05-12 | 2013-03-06 | Abbvie公司 | 激酶的吲唑抑制剂 |
| CA2812608C (en) | 2010-10-06 | 2020-07-14 | Glaxosmithkline Llc | Benzimidazole derivatives as pi3 kinase inhibitors |
| EP3083588B1 (en) | 2013-12-20 | 2020-12-09 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| WO2016004882A1 (en) | 2014-07-08 | 2016-01-14 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| TW201920150A (zh) | 2017-08-01 | 2019-06-01 | 美商施萬生物製藥研發 Ip有限責任公司 | 作為jak激酶抑制劑之吡唑并及三唑并雙環化合物 |
| EP3914348A1 (en) | 2019-01-23 | 2021-12-01 | Theravance Biopharma R&D IP, LLC | Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors |
| WO2021108803A1 (en) | 2019-11-26 | 2021-06-03 | Theravance Biopharma R&D Ip, Llc | Fused pyrimidine pyridinone compounds as jak inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5274097A (en) * | 1988-04-19 | 1993-12-28 | Bayer Aktiengesellschaft | 1,3-disubstituted pyrrolidines |
| DE3835291A1 (de) | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
| TW288010B (no) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| JPH09505029A (ja) * | 1993-07-19 | 1997-05-20 | 藤沢薬品工業株式会社 | ドパミン受容体作動薬、５−ＨＴ受容体拮抗薬あるいはα▲下１▼受容体拮抗薬として有用なベンズイミダゾール誘導体 |
| US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| JPH0940646A (ja) | 1995-07-27 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | ベンゼン縮合環誘導体又はその塩 |
| GB9523462D0 (en) * | 1995-11-16 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| WO1998050346A2 (en) * | 1997-04-18 | 1998-11-12 | Smithkline Beecham Plc | Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders |
| CA2378047A1 (en) * | 1999-07-15 | 2001-01-25 | Methvin Isaac | Heterocyclic compounds for the treatment of migraine |
| HUP0400684A2 (hu) * | 2000-12-22 | 2004-07-28 | Wyeth | 5-Hidroxitriptamin-6-ligandumként használható heterociklilindazol- és -azaindazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények |
| TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| TW200505904A (en) * | 2003-02-14 | 2005-02-16 | Wyeth Corp | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
-
2002
- 2002-04-19 EA EA200301143A patent/EA200301143A1/ru unknown
- 2002-04-19 WO PCT/US2002/012512 patent/WO2002085853A2/en active Application Filing
- 2002-04-19 EP EP02736592A patent/EP1392682A2/en not_active Withdrawn
- 2002-04-19 CA CA002444036A patent/CA2444036A1/en not_active Abandoned
- 2002-04-19 HU HU0303801A patent/HUP0303801A2/hu unknown
- 2002-04-19 AR ARP020101443A patent/AR034588A1/es not_active Application Discontinuation
- 2002-04-19 AU AU2002309585A patent/AU2002309585B2/en not_active Expired - Fee Related
- 2002-04-19 PL PL02366639A patent/PL366639A1/xx unknown
- 2002-04-19 JP JP2002583380A patent/JP2004526781A/ja active Pending
- 2002-04-19 MX MXPA03009490A patent/MXPA03009490A/es active IP Right Grant
- 2002-04-19 KR KR10-2003-7013584A patent/KR20030088507A/ko not_active Withdrawn
- 2002-04-19 CN CNB028123409A patent/CN1293073C/zh not_active Expired - Fee Related
- 2002-04-19 US US10/126,805 patent/US6831094B2/en not_active Expired - Fee Related
- 2002-04-19 BR BR0209047-3A patent/BR0209047A/pt not_active IP Right Cessation
- 2002-04-19 IL IL15844802A patent/IL158448A0/xx unknown
-
2003
- 2003-10-17 NO NO20034647A patent/NO20034647L/no not_active Application Discontinuation
- 2003-11-19 ZA ZA200309009A patent/ZA200309009B/en unknown
-
2004
- 2004-09-24 US US10/949,061 patent/US20050065185A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030088507A (ko) | 2003-11-19 |
| CN1293073C (zh) | 2007-01-03 |
| WO2002085853A2 (en) | 2002-10-31 |
| EP1392682A2 (en) | 2004-03-03 |
| ZA200309009B (en) | 2005-02-21 |
| AR034588A1 (es) | 2004-03-03 |
| HUP0303801A2 (hu) | 2004-03-01 |
| EA200301143A1 (ru) | 2004-02-26 |
| CN1518548A (zh) | 2004-08-04 |
| US20050065185A1 (en) | 2005-03-24 |
| CA2444036A1 (en) | 2002-10-31 |
| PL366639A1 (en) | 2005-02-07 |
| MXPA03009490A (es) | 2004-02-12 |
| NO20034647D0 (no) | 2003-10-17 |
| BR0209047A (pt) | 2004-08-10 |
| US6831094B2 (en) | 2004-12-14 |
| IL158448A0 (en) | 2004-05-12 |
| AU2002309585B2 (en) | 2008-01-31 |
| US20030078286A1 (en) | 2003-04-24 |
| JP2004526781A (ja) | 2004-09-02 |
| WO2002085853A3 (en) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20034648D0 (no) | Hydroksycyklyloksy-, tioksy- og -aminobenzazol-derivater som 5-hydroksytryptamin-6-ligander | |
| DK1353904T3 (da) | 1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander | |
| DK1456206T3 (da) | Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander | |
| NO20031977L (no) | 1-aryl- eller 1-alkylsulfonyl-heterocyklylbenzazoler som 5- hydroksytryptamin-6-ligander | |
| DK1355904T3 (da) | Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander | |
| NO20042279L (no) | Kinazolinderivater som antitumormidler | |
| NO20042288L (no) | Kinazolinderivater som antitumormidler | |
| NO20032531D0 (no) | Tetralon-derivater som antitumormidler | |
| NO20015477L (no) | 4,5,6,7-tetrahydroindazolderivater som antitumormidler | |
| DK1455779T3 (da) | Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander | |
| DK1509522T3 (da) | 1-(Aminoalkyl)-3-sulfonylazaindoler som 5-hydroxytryptamin-6-ligander | |
| NO20026195D0 (no) | Substituerte-triazolopyrimidiner som anticancer midler | |
| ATE319451T1 (de) | Tetrahydrochinolin-derivate | |
| ATE312827T1 (de) | 3-substituierte-4-pyrimidonderivate | |
| NO20041316L (no) | Tiofen- og tiazoisulfonamider som antineoplastiske midler | |
| NO20034647D0 (no) | Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-ligander | |
| DK1355900T3 (da) | Heterocyclylalkylindol- eller -azaindolforbindelser som 5-hydroxytryptamin-6-ligander | |
| NO20033234L (no) | Karotenoider som antihypertensjonsmidler | |
| DE60223031D1 (de) | Arylpiperazin gebundene tetrahydroindolonderivate | |
| DE60220799D1 (de) | Hypoglykämisches mittel | |
| DE60136966D1 (de) | Pflanzenstärkendes mittel | |
| DE60202381D1 (de) | Paroxetin-n-formyl-derivate | |
| IS7131A (is) | Nýjar 2,4-díamínóþíasól afleiður | |
| DK1380585T3 (da) | Pyrazolopyridinon som mellemprodukt | |
| DK1177185T3 (da) | 4,5,6,7-tetrahydroindazolderivater som antitumormidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |